Role of schools in the transmission of measles in rural Senegal: Implications for measles control in developing countries

American Journal of Epidemiology

Volumn 149, Issue 4, 1999, Pages 295-301

  Cisse, Badara ^a,b   Aaby, Peter ^a,b   Simondon, François ^a,c   Samb, Badara ^a,d   Soumaré, Masserigne ^e   Whittle, Hilton ^f  

^a Inst Francais Rech Sci pour le D   (Senegal)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d INSERM   (France)

^e Centre Hospitalier Universitaire Dakar   (Senegal)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Developing countries; Disease outbreaks; Disease transmission; Measles; Measles vaccine; Schools; Vaccination

Indexed keywords

MEASLES VACCINE;

DISEASE TRANSMISSION; MEASLES; VACCINATION;

ABSENTEEISM; ADOLESCENT; ADULT; ARTICLE; CHILD; DEVELOPING COUNTRY; EPIDEMIC; FATALITY; HEALTH PROMOTION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; RISK ASSESSMENT; RURAL AREA; SCHOOL; SENEGAL; VIRUS TRANSMISSION;

SENEGAL;

EID: 0033557392     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009811     Document Type: Article

References (23)

1. Markowitz LE, Preblud SR, Orenstein WA, et al. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med 1989;320:75-81.
2. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162: 1036-42.
3. Hutchins SS, Markowitz LE, Mead P, et al. A school-based measles outbreak: the effect of selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol 1990; 132:157-68.
4. Aaby P, Bukh J, Lisse IM, et al. Introduction of measles into a highly immunised West African community: the role of health care institutions. J Epidemiol Community Health 1985;39: 113-16.
5. Chen RT, Weierbach R, Bisoffi Z, et al. A "post-honeymoon period" measles outbreak in Muyinga sector, Burundi. Int J Epidemiol 1994;23:185-93.
6. Samb B, Aaby P, Whittle H, et al. Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal. Am J Epidemiol 1997;145:51-7.
7. Garenne M, Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis 1990;161:1088-94.
8. Samb B, Simondon F, Aaby P, et al. Prophylactic use of antibiotics and reduced case fatality in measles infection. Pediatr Infect Dis J 1995;14:695-6.
9. Garenne M, Leroy O, Beau JP, et al. Efficacy of measles vaccines after controlling for exposure. Am J Epidemiol 1993; 138:182-95.
10. Chahnazarian A, Becker C, Delaunay V, et al. Population et santé a Niakhar, 1984-1991. Dakar, Senegal: Institut Français de la Recherche Scientifique pour le Développement en Coopération (ORSTOM), 1992.
11. Aaby P. Influence of cross-sex transmission on measles mortality in rural Senegal. Lancet 1992;340:388-91.
12. Aaby P, Samb B, Simondon F, et al. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal. Bull World Health Organ 1994;72:761-70.
13. World Health Organization, Expanded Programme on Immunization. Global measles eradication: target 2010? (Editorial). EPI Newslett 1996;18(4):1-3.
14. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996;275: 224-9.
15. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 1988;10:212-41.
16. Samb B, Aaby P, Whittle H, et al. Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal. Trans R Soc Trop Med Hyg 1993;87:697-701.
17. Lisse I, Samb B, Whittle B, et al. Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles: a community study from rural Senegal. Scand J Infect Dis 1998;30:17-21.
18. Whittle H, Aaby P, Samb B, et al. The importance of subclinical measles in maintaining immunity in vaccinated children in West Africa. Lancet (in press).
19. Aaby P, Samb B, Simondon F, et al. Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal. Vaccine 1996;14:226-9.
20. Whittle HC, Aaby P, Samb B, et al. Serological responses 5-7 years after immunization with high and standard titre measles vaccines. Pediatr Infect Dis J (in press).
21. Aaby P, Bukh J, Leerhøy J, et al. Vaccinated children get milder measles infection: a community study from Guinea-Bissau. J Infect Dis 1986;154:858-63.
22. Cherry JD, Feigin RD, Shackelford PG, et al. A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr 1973;82:802-8.
23. Brownlee J. Public health administration in epidemics of measles. Br Med J 1920;1:534-7.